We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Resolves Warning Letter, Gets FDA Complera Approval
Gilead Resolves Warning Letter, Gets FDA Complera Approval
September 8, 2011
Gilead Sciences received double good news from the FDA, as the agency said the manufacturing problems at its San Dimas, Calif., plant are resolved and it approved Gilead’s three-drug fixed-dose combination HIV treatment Complera.